PRE 14A

PRE 14A Filing

Company: ZyVersa Therapeutics, Inc.
Filed: September 1, 2023
Period of Report: September 1, 2023
Accession Number: 0001493152-23-031497

View Document ↗ View on SEC.gov ↗